S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
Log in
ETR:AFX

Carl Zeiss Meditec Stock Forecast, Price & News

€121.20
-0.70 (-0.57 %)
(As of 03/5/2021 12:00 AM ET)
Add
Compare
Today's Range
€120.70
Now: €121.20
€122.50
50-Day Range
€113.70
MA: €129.68
€138.70
52-Week Range
€67.70
Now: €121.20
€140.50
Volume102,085 shs
Average Volume94,405 shs
Market Capitalization$10.84 billion
P/E Ratio83.18
Dividend Yield0.40%
BetaN/A
Carl Zeiss Meditec AG operates as a medical technology company in Germany, the United States, Japan, France, Spain, India, the United Kingdom, Turkey, North Africa, and internationally. It operates in two segments, Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment offers optical biometers, ophthalmic surgical microscopes, phacoemulsification/vitrectomy devices, intraocular lenses, and ophthalmic viscoelastic products for the diagnosis and treatment of ophthalmic diseases in the field of cataract and retinal surgery. This segment also offers optical coherence tomography devices, perimeters, fundus cameras, slit lamps, and therapeutic and refractive lasers for the diagnosis and treatment of various eye diseases, such as refraction, glaucoma, and other retinal diseases, as well as FORUM, an eye care data management system. The Microsurgery segment provides surgical microscopes and visualization solutions for neuro, spinal, dental, and plastic and reconstructive surgeries, as well as for ear, nose, and throat surgery; products for surgical treatment of tumors or vascular diseases, such as aneurysms; and INTRABEAM, a intraoperative radiotherapy device. Carl Zeiss Meditec AG serves ophthalmologists and optometrists, as well as physicians and surgeons in hospitals and outpatient surgery centers. The company was founded in 2002 and is headquartered in Jena, Germany. Carl Zeiss Meditec AG is a subsidiary of Carl Zeiss AG.
Carl Zeiss Meditec logo

Headlines

Carl Zeiss Meditec Q1 Profit Rises - Quick Facts
January 19, 2021 |  nasdaq.com
ZEISS presents integrated workflow advancements at AAO
November 12, 2020 |  prnewswire.com
See More Headlines

Industry, Sector and Symbol

Industry Diagnostics & Research
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+49-3641-2200
Employees3,290
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.33 billion
Cash Flow€0.06 per share
Book Value€16.01 per share

Profitability

Miscellaneous

Market Cap$10.84 billion
Next Earnings Date5/10/2021 (Estimated)
OptionableNot Optionable

MarketRank

Overall MarketRank

1.03 out of 5 stars

Analyst Opinion: 2.0Community Rank: 2.3Dividend Strength: 0.8Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
€121.20
-0.70 (-0.57 %)
(As of 03/5/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive AFX News and Ratings via Email

Sign-up to receive the latest news and ratings for AFX and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Carl Zeiss Meditec (ETR:AFX) Frequently Asked Questions

Is Carl Zeiss Meditec a buy right now?

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Carl Zeiss Meditec in the last twelve months. There are currently 2 sell ratings, 4 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" Carl Zeiss Meditec stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in AFX, but not buy additional shares or sell existing shares.
View analyst ratings for Carl Zeiss Meditec
or view top-rated stocks.

What stocks does MarketBeat like better than Carl Zeiss Meditec?

Wall Street analysts have given Carl Zeiss Meditec a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Carl Zeiss Meditec wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Carl Zeiss Meditec's next earnings date?

Carl Zeiss Meditec is scheduled to release its next quarterly earnings announcement on Monday, May 10th 2021.
View our earnings forecast for Carl Zeiss Meditec
.

How has Carl Zeiss Meditec's stock price been impacted by COVID-19 (Coronavirus)?

Carl Zeiss Meditec's stock was trading at €84.30 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, AFX shares have increased by 43.8% and is now trading at €121.20.
View which stocks have been most impacted by COVID-19
.

Is Carl Zeiss Meditec a good dividend stock?

Carl Zeiss Meditec pays an annual dividend of €0.50 per share and currently has a dividend yield of 0.40%. The dividend payout ratio of Carl Zeiss Meditec is 34.32%. This payout ratio is at a healthy, sustainable level, below 75%.
View Carl Zeiss Meditec's dividend history.

What price target have analysts set for AFX?

8 brokerages have issued twelve-month price objectives for Carl Zeiss Meditec's stock. Their forecasts range from €80.00 to €150.00. On average, they anticipate Carl Zeiss Meditec's stock price to reach €118.86 in the next twelve months. This suggests that the stock has a possible downside of 1.9%.
View analysts' price targets for Carl Zeiss Meditec
or view top-rated stocks among Wall Street analysts.

Who are Carl Zeiss Meditec's key executives?

Carl Zeiss Meditec's management team includes the following people:
  • Dr. Ludwin Monz, Pres, CEO & Chairman of Management Board (Age 58, Pay $1.31M)
  • Mr. Justus Felix Wehmer, CFO & Member of the Management Board (Age 56, Pay $515.3k)
  • Mr. Jan Willem de Cler, Head of Surgical Ophthalmology & Member of Management Board
  • Mr. Sebastian Frericks, Director of Investor Relations
  • Mr. Martin Wiechmann, Head of the Planetarium Bus. Unit
  • Mr. Mike Wang, Head of Marketing - Shanghai
  • Mr. Steven C. Schallhorn M.D., Chief Medical Officer for Global Ophthalmic Devices
  • Mr. Andrew Chang, Head of Sales for Ophthalmic Devices & Pres of Carl Zeiss Meditec, Inc.
  • Laurie Ferguson, Head of Global Communications Ophthalmic Devices
  • Dr. Euan S. Thomson, Pres of Ophthalmic Devices & Head of the Ophthalmic Devices Strategic Bus. Unit (Age 58)

Who are some of Carl Zeiss Meditec's key competitors?

What other stocks do shareholders of Carl Zeiss Meditec own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Carl Zeiss Meditec investors own include Covestro (1COV), AbbVie (ABBV), AmerisourceBergen (ABC), Allianz SE (ALV.F) (ALV), Daimler AG (DAI.F) (DAI), Gilead Sciences (GILD), Intel (INTC), NVIDIA (NVDA), QUALCOMM (QCOM) and SAP (SAP).

What is Carl Zeiss Meditec's stock symbol?

Carl Zeiss Meditec trades on the ETR under the ticker symbol "AFX."

What is Carl Zeiss Meditec's stock price today?

One share of AFX stock can currently be purchased for approximately €121.20.

How much money does Carl Zeiss Meditec make?

Carl Zeiss Meditec has a market capitalization of $10.84 billion and generates $1.33 billion in revenue each year.

How many employees does Carl Zeiss Meditec have?

Carl Zeiss Meditec employs 3,290 workers across the globe.

What is Carl Zeiss Meditec's official website?

The official website for Carl Zeiss Meditec is www.zeiss.com.

Where are Carl Zeiss Meditec's headquarters?

Carl Zeiss Meditec is headquartered at Goeschwitzer Strasse 51-52, JENA, 07745, Germany.

How can I contact Carl Zeiss Meditec?

Carl Zeiss Meditec's mailing address is Goeschwitzer Strasse 51-52, JENA, 07745, Germany. The company can be reached via phone at +49-3641-2200.


This page was last updated on 3/6/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.